Degenerative mitral valve disease is the leading cause of mitral regurgitation in North America. Surgical intervention has hinged on the symptoms and ventricular changes that develop as compensatory ventricular remodeling occurs. In the present study, we sought to characterize the temporal response of left ventricular (LV) morphology and function to mitral valve surgery for degenerative disease and to identify the preoperative factors that influence reverse remodeling. From 1986 to 2007, 2,778 patients with isolated degenerative mitral valve disease underwent valve repair (n = 2,607 [94%]) or replacement (n = 171 [6%]) and had ≥1 postoperative transthoracic echocardiogram; 5,336 transthoracic echocardiograms were available for analysis. Multivariate longitudinal repeated-measures analysis was performed to identify the factors associated with reverse remodeling. The LV dimensions decreased in the first year after surgery (end-diastolic from 5.7 ± 0.80 to 4.9 ± 1.4 cm; end-systolic from 3.4 ± 0.71 to 3.1 ± 1.4 cm). The LV mass index decreased from 139 ± 44 to 112 ± 73 g/m 2 . The reduction in LV hypertrophy was less pronounced in patients with greater preoperative left heart enlargement (p <0.0001) and a greater preoperative LV mass (p <0.0001). The postoperative LV ejection fraction initially decreased from 58 ± 7.0% to 53 ± 20%, increased slightly during the first postoperative year, and was negatively influenced by preoperative heart failure symptoms (p <0.0001) and a lower preoperative LV ejection fraction (p <0.0001). The risk-adjusted response of LV morphology and function to valve repair and replacement was similar (p >0.2). In conclusion, a positive response toward normalization of LV morphology and function after mitral valve surgery is greatest in the first year. The best response occurs when surgery is performed before left heart dilation, LV hypertrophy, or LV dysfunction develop.
Progression of degenerative mitral valve (MV) disease is characterized by ventricular remodeling, whereby adaptive changes occur to accommodate the regurgitant volume and maintain cardiac output. Current surgical indications for severe degenerative mitral regurgitation (MR) are based on the onset of symptoms, changes in left ventricular (LV) function or dimensions, and development of atrial fibrillation or pulmonary hypertension. Our group and others have documented improved clinical outcomes with early intervention and reduced long-term survival in patients with LV dysfunction undergoing MV surgery. To investigate various clinical outcomes, we focused on the ventricular remodeling process that occurs in chronic degenerative MR. In the present study, we sought to characterize the responses of LV morphology and function to MV surgery and identify the preoperative factors modulating this postoperative response.
Methods
From January 1986 to January 2007, 3,031 patients underwent primary isolated MV surgery for degenerative MR at Cleveland Clinic. Those undergoing concomitant ablation procedures for atrial fibrillation (except a full cut-and-sew Maze procedure) or tricuspid valve procedures for functional regurgitation were considered to have secondary consequences of degenerative MV disease and were included in the present study. However, those with a history of previous cardiac surgery or concomitant coronary artery bypass or aortic valve procedures were excluded. Patients with epicardial coronary artery stenosis ≥50% were also excluded, as were patients with a history of coronary intervention.
To assess the postoperative changes in LV morphology and function, we required ≥1 postoperative transthoracic echocardiogram. Using the Cleveland Clinic echocardiographic database, we determined that 2,778 (92%) of the 3,031 patients had undergone such an examination, and they formed the final study group. Of these, 2,607 (94%) underwent MV repair and 171 (6%) MV replacement. A summary of the patient demographics and clinical and echocardiographic characteristics is provided in Table 1 . Clinical data were retrieved from the prospective Cardiovascular Information Registry. This registry has been approved for use in research by the institutional review board, with patient consent waived.
Variable | Overall (n = 2,778) | MV Repair (n = 2,607) | MV Replacement (n = 171) | p Value ⁎ | |||
---|---|---|---|---|---|---|---|
n † | Value | n † | Value | n † | Value | ||
Age (years) | 2,778 | 57 ± 13 | 2,607 | 56 ± 13 | 171 | 69 ± 13 | <0.0001 |
Body surface area (m 2 ) | 2,772 | 2.0 ± 0.24 | 2,602 | 2.0 ± 0.24 | 170 | 1.9 ± 0.27 | <0.0001 |
Women | 2,778 | 970 (35%) | 2,607 | 876 (34%) | 171 | 94 (55%) | <0.0001 |
New York Heart Association functional class | 2,776 | 2,605 | 171 | <0.0001 | |||
I | 814 (29%) | 790 (30%) | 24 (14%) | ||||
II | 1,558 (56%) | 1,463 (56%) | 95 (56%) | ||||
III | 357 (13%) | 309 (12%) | 48 (28%) | ||||
IV | 47 (1.7%) | 43 (1.7%) | 4 (2.3%) | ||||
Mitral regurgitation grade | 2,748 | 2,579 | 169 | 0.04 | |||
2+ | 7 (0.25%) | 8 (0.31%) | 1 (0.59%) | ||||
3+ | 219 (8.0%) | 213 (8.3%) | 23 (14%) | ||||
4+ | 2,522 (92%) | 2,358 (91%) | 145 (86%) | ||||
Leaflet prolapse | 2,778 | 2,607 | 171 | ||||
Posterior only | 1,243 (45%) | 1,193 (47%) | 50 (29%) | <0.0001 | |||
Anterior only | 174 (6.3%) | 147 (5.6%) | 27 (16%) | <0.0001 | |||
Bileaflet | 1,338 (48%) | 1,258 (48%) | 81 (47%) | 0.8 | |||
Ruptured chordae | 2,778 | 2,607 | 171 | <0.0001 | |||
Posterior | 1,576 (57%) | 1,511 (58%) | 65 (38%) | ||||
Anterior | 271 (9.8%) | 231 (8.9%) | 40 (23%) | ||||
Mitral valve calcification | 2,778 | 614 (22%) | 2,607 | 521 (20%) | 171 | 93 (54%) | <0.0001 |
Tricuspid regurgitation grade | 2,370 | 2,226 | 144 | <0.0001 | |||
0 | 901 (38%) | 882 (40%) | 19 (13%) | ||||
1+ | 862 (36%) | 821 (37%) | 41 (28%) | ||||
2+ | 413 (17%) | 369 (17%) | 44 (31%) | ||||
3+ | 149 (6.3%) | 121 (5.4%) | 28 (19%) | ||||
4+ | 45 (1.9%) | 33 (1.5%) | 12 (8.3%) | ||||
Echocardiographic assessment | |||||||
Left atrium diameter (cm) | 2,575 | 4.9 ± 0.90 | 2,422 | 4.9 ± 0.88 | 153 | 5.3 ± 1.02 | <0.0001 |
Left ventricular end-diastolic diameter (cm) | 2,698 | 5.7 ± 0.80 | 2,540 | 5.8 ± 0.79 | 158 | 5.5 ± 0.93 | <0.0001 |
Left ventricular end-systolic diameter (cm) | 2,678 | 3.4 ± 0.71 | 2,517 | 27 ± 13 | 155 | 26 ± 15 | 0.3 |
Left ventricular mass index (g/m 2 ) | 2,623 | 139 ± 44 | 2,468 | 138 ± 43 | 155 | 147 ± 44 | 0.006 |
Left ventricular ejection fraction (%) | 2,706 | 58 ± 7.4 | 2,538 | 58 ± 7.4 | 168 | 56 ± 8.0 | 0.0003 |
Cardiac co-morbidity | |||||||
Heart failure | 2,778 | 634 (23%) | 2,607 | 547 (21%) | 171 | 87 (51%) | <0.0001 |
Ventricular arrhythmia | 2,655 | 357 (13%) | 2,498 | 329 (13%) | 157 | 28 (18%) | 0.1 |
Atrial fibrillation/flutter | 2,778 | 343 (12%) | 2,607 | 286 (11%) | 171 | 57 (33%) | <0.0001 |
Complete heart block | 2,778 | 43 (1.5%) | 2,607 | 28 (1.1%) | 171 | 15 (8.8%) | <0.0001 |
Concomitant procedures | |||||||
Ablation for atrial fibrillation | 2,778 | 60 (2.2%) | 2,607 | 48 (1.8%) | 171 | 12 (7.0%) | <0.0001 |
Tricuspid valve procedure | 2,778 | 159 (5.8%) | 2,607 | 121 (4.6%) | 171 | 38 (22%) | <0.0001 |
⁎ Unadjusted comparison between MV repair and replacement using Wilcoxon rank-sum nonparametric test (continuous variables) or chi-square test (categorical variables).
Transthoracic echocardiograms were performed routinely before discharge and at the discretion of referring physicians during follow-up. Intraoperative transesophageal echocardiograms were not used in the present report. The interpretation of follow-up echocardiograms was obtained at as many postoperative points as available for each patient. A total of 5,336 transthoracic echocardiographic records were available for the 2,778 patients. The distribution of the postoperative echocardiograms permitted assessment of temporal trends for ≤5 years ( eFigure 1 ).
Chamber measurements were derived from 2-dimensional images. The morphologic data recorded and analyzed for temporal responses included left atrial (LA) diameter (from which the LA volume was calculated ), end-diastolic and end-systolic LV diameters, and septal and posterior wall thickness (from which the LV mass was calculated). The LV end-diastolic volume, end-systolic volume, and ejection fraction were measured from multiple 2-dimensional projections by planimetry and edited by visual interpretation of all available views.
The interobserver variability in our echocardiographic laboratory is −0.1 mL (95% confidence interval [CI] −42.8 to 42.5) for the LV end-diastolic volume, 5.9 mL (95% CI −21.6 to 33.3) for the LV end-systolic volume, and −4% (95% CI −16.1% to 8.0%) for the LV ejection fraction. The corresponding intraobserver variability for these same 3 measurements was 7.1 mL (95% CI, −38.8 to 50), 4.4 mL (95% CI −27.9 to 36.7), and 0.0% (95% CI −13.3% to 13.3%).
To determine the temporal response to mitral surgery, the trends of repeated postoperative transthoracic echocardiographic measurements were analyzed longitudinally using a generalized nonlinear mixed model regression for continuous variables (SAS PROC NLMIXED). The temporal patterns of values were characterized by temporal decomposition for each transthoracic echocardiographic variable.
Multivariate analysis, using the variables listed in eAppendix 1 , was performed to identify the preoperative factors that modulated each temporal phase for the postoperative LV mass index and ejection fraction. We initially screened the variables using ordinary multivariate linear regression (PROC REG). Bootstrap bagging methods were used to identify the possible predictors with random resampling and automated stepwise selection. Variables or clusters of variables that entered >50% of 1,000 models then underwent refined generalized nonlinear mixed model regression analysis. Specific variables of interest (including tricuspid regurgitation, MV procedure [repair or replacement], and New York Heart Association functional classification) were forced into the analysis.
Sporadic missing values were imputed using fivefold multiple imputation (PROC MI). For each imputed complete data set, we estimated the regression coefficients and their variance–covariance matrix. We then combined the estimates from the 5 models using PROC MIANALYZE.
Continuous variables are summarized as the mean ± SD and as the 15th, 50th (median), and 85th percentiles. They were compared using Wilcoxon rank-sum nonparametric tests. Categorical data are summarized by frequencies and percentages and compared using chi-square tests. All analyses were performed using SAS statistical software, version 9.1 (SAS, Cary, North Carolina). Uncertainty is expressed by confidence limits equivalent to ±1 standard error (68%).